Liaoning Oxiranpharm is a Manufacturer/Innovator company operating in the pharmaceutical industry.
The company specializing in the production of medicinal polyethylene glycol (PEG) products. Have cooperative relationship with Petrochina for many years. In 2008 the company listed in China. Annual output of 20000, which is the domestic several big pharma’s strategic partner. Products are exported to Europe. South America, Australia. East Asia and other regions. CEP certification will be done in May 2024, Liaoning Oxiranpharm Inc. aiming to APIs as well.
Company type
Manufacturer/Innovator
Products and services
Biopharmaceuticals, Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Liaoning Oxiranpharm on LinkedIn
Address
Liaoning Oxiranpharm, No. 58, Wanhe ER Road,, Hongwei District, Liaoning, China, 111003
Stay ahead of trends and best practices
